Does Dr. PAUL EVANGELISTI have financial conflicts of interest?

Dr. PAUL EVANGELISTI (MD) has received a total of $1,447 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,447 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PAUL EVANGELISTI?

According to CMS Open Payments data, Dr. PAUL EVANGELISTI received funding from REGENERON HEALTHCARE SOLUTIONS ($325), GLAXOSMITHKLINE ($182), and INTEGRA LIFESCIENCES CORPORATION ($126).

Does Dr. PAUL EVANGELISTI receive research grants or speaking fees?

Dr. PAUL EVANGELISTI has received $1,447 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. PAUL EVANGELISTI

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: SUMTER, SC 29150

NPI Number: 1982625745

LIFETIME INDUSTRY VALUE

$1,447

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. EVANGELISTI is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in SUMTER, SC.

Between 2021 and 2025, Dr. EVANGELISTI had an overall industry promotional and research financial footprint of $1,447 as recorded in the federal CMS Open Payments database.

$1,447 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. EVANGELISTI's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $325 (representing 22.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$325

22.4%

GLAXOSMITHKLINE

Rank 2

$182

12.6%

INTEGRA LIFESCIENCES CORPORATION

Rank 3

$126

8.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.